Insights gained from conducting a randomised controlled trial on Ivermectin-Albendazole against Trichuris trichiura in Côte d'Ivoire, Lao PDR and Pemba Island.
Albendazole
Côte d'Ivoire
Ivermectin
Lao PDR
Pemba
Randomized controlled trial
Soil-transmitted helminths
Tanzania
Trial implementation
Trichuris trichiura
Journal
Advances in parasitology
ISSN: 2163-6079
Titre abrégé: Adv Parasitol
Pays: England
ID NLM: 0370435
Informations de publication
Date de publication:
2021
2021
Historique:
entrez:
23
1
2021
pubmed:
24
1
2021
medline:
7
9
2021
Statut:
ppublish
Résumé
There is only limited scientific literature on trial methodology, trial procedures and mitigation strategies to overcome challenges faced during clinical research taking place in resource constrained healthcare environments. Organisational, cultural, infrastructural and ethical challenges may vary between settings although conduct of clinical trials for the same disease (in our case soil-transmitted helminth (STH) infections) share similar risks for implementation. We use the example of a phase III randomised controlled trial, conducted between 2018 and 2020 in Côte d'Ivoire, Lao PDR and Pemba Island (Tanzania), to share challenges faced and mitigation strategies to guide future planning of studies in similar settings. We describe the planning, screening, enrolment and implementation phases in each of the three settings. Our findings indicate that involvement of local staff and close collaboration are essential factors for successful trial preparation and implementation. A strategic plan adapted to each setting with a distinct focus on community engagement and workforce is crucial to proceed efficiently. Mutual trust between the trial population and the trial team is of utmost importance and allows for early reaction and adaption to emerging issues.
Identifiants
pubmed: 33482976
pii: S0065-308X(20)30110-X
doi: 10.1016/bs.apar.2020.11.001
pii:
doi:
Substances chimiques
Anthelmintics
0
Ivermectin
70288-86-7
Albendazole
F4216019LN
Types de publication
Clinical Trial, Phase III
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
253-276Informations de copyright
© 2021 Elsevier Ltd. All rights reserved.